Contract 75N93020C00021

Inimmune Corp · Department Of Health And Human Services · May 28, 2020

Small Business Set Aside - TotalFirm Fixed PriceFull & Open CompetitionNAICS 541715

Inimmune Corp was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on May 28, 2020 for $1.99 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Missoula, MT. It was awarded under a small business set-aside. The contract has been modified 7 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on May 24, 2022.

Obligated to date
$1.99M
$1,992,471
Current value
$1.99M
Modifications
7
Latest May 24, 2022

Contract details

PIID
75N93020C00021
Award type
Definitive Contract
Pricing
Firm Fixed Price
Set-aside
Small Business Set Aside - Total
Competition
Full And Open Competition After Exclusion Of Sources
NAICS
541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
Product / service
Health R&D Services; Health Care Services; Applied Research
Place of performance
Missoula, MT
First action
May 28, 2020
Latest action
May 24, 2022

Description

PRODUCTION OF SYNTHETIC ADJUVANT SYSTEM (SAS): A SYNERGISTIC COMBINATION OF SYNTHETIC ADJUVANT COMPONENTS

Modification timeline

  • May 24, 2022
    Mod P00006
    $0
  • May 19, 2022
    Mod P00007
    $0
  • February 25, 2022
    Mod P00005
    $0
  • October 13, 2021
    Mod P00004
    EO14042 - PRODUCTION OF SYNTHETIC ADJUVANT SYSTEM (SAS): A SYNERGISTIC COMBINATION OF SYNTHETIC ADJUVANT COMPONENTS
    $0
  • September 29, 2021
    Mod P00002
    $0
  • September 29, 2021
    Mod P00003
    $0
  • October 29, 2020
    Mod P00001
    $0
  • May 28, 2020
    Base award
    $1.99M

Similar contracts

RecipientAgencyDateObligated
The Emmes Company, LlcDepartment Of Health And Human ServicesApril 1, 2026$771.5K
Leidos Biomedical Research IncDepartment Of Health And Human ServicesApril 1, 2026$8.00M
Leidos Biomedical Research IncDepartment Of Health And Human ServicesApril 1, 2026$9.22M
Leidos Biomedical Research IncDepartment Of Health And Human ServicesApril 1, 2026$327.13M
The Brain Donor Project, IncDepartment Of Health And Human ServicesApril 1, 2026$1.27M
Leidos Biomedical Research IncDepartment Of Health And Human ServicesApril 1, 2026$20.43M

Top contractors in NAICS 541715

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 75N93020C00021?

Contract 75N93020C00021 is a federal contract awarded to Inimmune Corp by Department Of Health And Human Services on May 28, 2020 for $1.99 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 7 times since the base award.

Who won contract 75N93020C00021?

Inimmune Corp won contract 75N93020C00021 from Department Of Health And Human Services.

How much is contract 75N93020C00021 worth?

Contract 75N93020C00021 has obligated $1.99 million to date.